KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Novavax (NVAX) over the last 17 years, with Q3 2025 value amounting to $263.5 million.

  • Novavax's Other Non-Current Liabilities fell 1738.2% to $263.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $263.5 million, marking a year-over-year decrease of 1738.2%. This contributed to the annual value of $359.6 million for FY2024, which is 98546.33% up from last year.
  • Per Novavax's latest filing, its Other Non-Current Liabilities stood at $263.5 million for Q3 2025, which was down 1738.2% from $287.6 million recorded in Q2 2025.
  • In the past 5 years, Novavax's Other Non-Current Liabilities ranged from a high of $359.6 million in Q4 2024 and a low of $20.6 million during Q2 2021
  • Over the past 5 years, Novavax's median Other Non-Current Liabilities value was $66.8 million (recorded in 2022), while the average stood at $146.8 million.
  • As far as peak fluctuations go, Novavax's Other Non-Current Liabilities plummeted by 6216.25% in 2023, and later skyrocketed by 98546.33% in 2024.
  • Over the past 5 years, Novavax's Other Non-Current Liabilities (Quarter) stood at $42.1 million in 2021, then skyrocketed by 32.23% to $55.7 million in 2022, then crashed by 40.52% to $33.1 million in 2023, then soared by 985.46% to $359.6 million in 2024, then dropped by 26.73% to $263.5 million in 2025.
  • Its Other Non-Current Liabilities was $263.5 million in Q3 2025, compared to $287.6 million in Q2 2025 and $313.7 million in Q1 2025.